Provided by Tiger Trade Technology Pte. Ltd.

Century Therapeutics, Inc.

2.05
+0.02501.23%
Post-market: 2.01-0.0400-1.95%16:19 EDT
Volume:373.10K
Turnover:756.79K
Market Cap:371.05M
PE:-2.20
High:2.06
Open:2.00
Low:1.97
Close:2.03
52wk High:3.04
52wk Low:0.4350
Shares:181.00M
Float Shares:101.00M
Volume Ratio:0.79
T/O Rate:0.37%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9300
EPS(LYR):-0.1107
ROE:-49.65%
ROA:-23.51%
PB:1.60
PE(LYR):-18.52

Loading ...

Century Therapeutics Q1 Operating Income USD -23.684 Million

THOMSON REUTERS
·
May 13

Press Release: Century Therapeutics Reports First Quarter Financial Results and Business Updates

Dow Jones
·
May 13

Century Therapeutics Inc expected to post a loss of 16 cents a share - Earnings Preview

Reuters
·
May 01

Century Therapeutics to give oral presentation of CNTY-813 preclinical data at ADA Scientific Sessions

Reuters
·
May 01

Century Therapeutics Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Apr 21

Century Therapeutics price target raised to $5 from $2 at H.C. Wainwright

TIPRANKS
·
Apr 21

Century Therapeutics director Martin Patrick Murphy files initial beneficial ownership statement

Reuters
·
Apr 11

Corrected-Century Therapeutics Inc - Sold $18.4 Mln in Common Stock Through TD Cowen - SEC Filing (Not 'May Offer $150 Mln')

THOMSON REUTERS
·
Mar 27

Century Therapeutics Updates ATM Program to Enhance Liquidity

TIPRANKS
·
Mar 27

Century Therapeutics updates $150.0 million ATM program; $131.6 million remains available for sale

Reuters
·
Mar 27

Century Therapeutics Inc - May Offer up to $150 Mln in Common Stock Through TD Cowen - SEC Filing

THOMSON REUTERS
·
Mar 27

Century Therapeutics Rocked by Dual Insider Moves at the Top

TIPRANKS
·
Mar 17

Century Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
Mar 12

Century Therapeutics Reports 2025 Results and Pipeline Progress

TIPRANKS
·
Mar 12

Century Therapeutics Q4 EPS $(0.25) Beats $(0.27) Estimate

Benzinga Earnings
·
Mar 12

Century Therapeutics 2025 net loss narrows beating estimates

Reuters
·
Mar 12

Century Therapeutics FY2025 net loss narrows 92% to USD 9.58 million on collaboration revenue of USD 109.16 million

Reuters
·
Mar 12

BRIEF-Century Therapeutics FY Net Income USD -9.58 Million

Reuters
·
Mar 12

Century Therapeutics FY Operating Expenses USD 126.433 Million

THOMSON REUTERS
·
Mar 12

Century Therapeutics Inc - Cnty-813 Ind Submission Expected in Q4 2026; Initial Clinical Data Anticipated in 2H 2027

THOMSON REUTERS
·
Mar 12